Author

Anirudh Rao

Stanford MedicineORCID 0009-0001-0801-2183Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 1 Approach:genetic perturbation / CRISPR· 1 Organism:human· 1 Organism:mouse· 1

Frequent Co-Authors

Imran MohammadiD· 1 shared Jeremy R. VillafuerteiD· 1 shared John B. SunwooiD· 1 shared Kostas Stiklioraitis· 1 shared Le CongiD· 1 shared Pari GunasekaraniD· 1 shared Ravi K. DineshiD· 1 shared Rogelio Antonio Hernández-LópeziD· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

9 top collaborators · 36 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

Imran MohammadORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Surfaceome CRISPR activation screening uncovers ligands regulating tumor sensitivity to NK cell killing

Ravi K. Dinesh, Xiaotong Wang, Imran Mohammad, Pari Gunasekaran, Kostas Stiklioraitis, Jeremy R. Villafuerte, Anirudh Rao, Rogelio Antonio Hernández-López, John B. Sunwoo, Le Cong

This study uses CRISPR activation screening to identify surface ligands that regulate tumor sensitivity to NK cell killing, revealing new targets for improving NK cell-based immunotherapies.

Nature Communications · Aug 6, 2026Peer-reviewedImmunology